Sopharma Trading AD (BUL:SFT)
Bulgaria
· Delayed Price · Currency is BGN · Price in EUR 3.300
-0.120 (-3.51%)
At close: Mar 6, 2026
Sopharma Trading AD Income Statement
Financials in millions BGN. Fiscal year is January - December.
Millions BGN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 2,280 | 1,942 | 1,673 | 1,479 | 1,336 | Upgrade
|
| Other Revenue | 18.44 | 9.41 | 5.06 | 4.26 | - | Upgrade
|
| Revenue | 2,299 | 1,951 | 1,678 | 1,483 | 1,336 | Upgrade
|
| Revenue Growth (YoY) | 17.81% | 16.25% | 13.20% | 11.00% | 15.53% | Upgrade
|
| Cost of Revenue | 12.47 | 1,701 | 1,482 | 1,311 | 1,193 | Upgrade
|
| Gross Profit | 2,286 | 250.08 | 196.01 | 172.13 | 142.34 | Upgrade
|
| Selling, General & Admin | 2,150 | 149.07 | 115.57 | 100.73 | 97.75 | Upgrade
|
| Other Operating Expenses | 9.32 | 4.03 | 3.61 | 1.47 | -0.29 | Upgrade
|
| Operating Expenses | 2,204 | 190.02 | 151.29 | 132.26 | 126.29 | Upgrade
|
| Operating Income | 82.21 | 60.05 | 44.71 | 39.87 | 16.05 | Upgrade
|
| Interest Expense | -14.13 | -9.76 | -8.42 | -5.18 | -5.36 | Upgrade
|
| Interest & Investment Income | - | 1.1 | 0.47 | 0.71 | 2.11 | Upgrade
|
| Earnings From Equity Investments | -0.05 | -0.01 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | -4.47 | -0.13 | -0.11 | -0.16 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.28 | -0.71 | -2.63 | -1.75 | -0.97 | Upgrade
|
| EBT Excluding Unusual Items | 70.31 | 46.22 | 34 | 33.55 | 11.66 | Upgrade
|
| Merger & Restructuring Charges | - | -0.12 | - | - | - | Upgrade
|
| Impairment of Goodwill | - | - | - | -13.33 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 0.57 | 0.21 | 0.46 | 0.3 | Upgrade
|
| Asset Writedown | - | - | - | -8.28 | -2.64 | Upgrade
|
| Other Unusual Items | - | 0.34 | - | - | 0.12 | Upgrade
|
| Pretax Income | 70.31 | 47.01 | 34.21 | 12.39 | 9.44 | Upgrade
|
| Income Tax Expense | 7.09 | 7.23 | 5 | 3.31 | 1.39 | Upgrade
|
| Earnings From Continuing Operations | 63.22 | 39.78 | 29.21 | 9.08 | 8.05 | Upgrade
|
| Minority Interest in Earnings | -0.3 | 0.49 | - | - | - | Upgrade
|
| Net Income | 62.92 | 40.27 | 29.21 | 9.08 | 8.05 | Upgrade
|
| Net Income to Common | 62.92 | 40.27 | 29.21 | 9.08 | 8.05 | Upgrade
|
| Net Income Growth | 56.24% | 37.87% | 221.67% | 12.80% | -29.85% | Upgrade
|
| Shares Outstanding (Basic) | 34 | 34 | 34 | 34 | 34 | Upgrade
|
| Shares Outstanding (Diluted) | 34 | 34 | 34 | 34 | 34 | Upgrade
|
| Shares Change (YoY) | -0.11% | -0.13% | - | - | - | Upgrade
|
| EPS (Basic) | 1.84 | 1.18 | 0.85 | 0.26 | 0.23 | Upgrade
|
| EPS (Diluted) | 1.84 | 1.18 | 0.85 | 0.26 | 0.23 | Upgrade
|
| EPS Growth | 56.41% | 38.05% | 221.67% | 12.80% | -29.85% | Upgrade
|
| Free Cash Flow | -21.05 | 54.64 | 37.63 | 12.84 | -180.39 | Upgrade
|
| Free Cash Flow Per Share | -0.62 | 1.60 | 1.10 | 0.38 | -5.26 | Upgrade
|
| Gross Margin | 99.46% | 12.82% | 11.68% | 11.61% | 10.66% | Upgrade
|
| Operating Margin | 3.58% | 3.08% | 2.66% | 2.69% | 1.20% | Upgrade
|
| Profit Margin | 2.74% | 2.06% | 1.74% | 0.61% | 0.60% | Upgrade
|
| Free Cash Flow Margin | -0.92% | 2.80% | 2.24% | 0.87% | -13.50% | Upgrade
|
| EBITDA | 126.54 | 93.21 | 73.53 | 67.21 | 28.08 | Upgrade
|
| EBITDA Margin | 5.50% | 4.78% | 4.38% | 4.53% | 2.10% | Upgrade
|
| D&A For EBITDA | 44.33 | 33.16 | 28.82 | 27.34 | 12.03 | Upgrade
|
| EBIT | 82.21 | 60.05 | 44.71 | 39.87 | 16.05 | Upgrade
|
| EBIT Margin | 3.58% | 3.08% | 2.66% | 2.69% | 1.20% | Upgrade
|
| Effective Tax Rate | 10.08% | 15.37% | 14.62% | 26.73% | 14.70% | Upgrade
|
| Advertising Expenses | - | 11.21 | 6.55 | 4.14 | 3.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.